Janux Therapeutics, Inc. (JANX)

Typically moves ±3.86% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Across 21 earnings reports since Aug 10, 2021, Janux Therapeutics, Inc. (JANX) has a clear post-earnings pattern. It moves ±3.86% on average after reporting and finishes higher 52.4% of the time. Its largest post-earnings gain was +11.88% (Aug 09, 2022) and its largest decline was -9.49% (Mar 18, 2022). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How JANX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±3.86%

Positive %

52.4%

Negative %

47.6%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 06, 2026	☽ POST	-1.37%	open_in_new
May 07, 2026	☽ POST	-2.44%	open_in_new
Feb 26, 2026	☽ POST	-1.38%	open_in_new
Nov 06, 2025	☽ POST	-7.61%	open_in_new
Aug 07, 2025	☽ POST	+1.11%	open_in_new
May 08, 2025	☽ POST	-3.07%	open_in_new
Feb 27, 2025	☽ POST	+2.75%	open_in_new
Nov 06, 2024	☽ POST	-1.24%	open_in_new
Aug 07, 2024	☽ POST	+3.4%	open_in_new
May 08, 2024	☽ POST	-6.19%	open_in_new
Mar 08, 2024	☽ POST	+0.4%	open_in_new
Nov 07, 2023	☽ POST	+0.91%	open_in_new
Aug 08, 2023	☽ POST	+6.82%	open_in_new
May 09, 2023	☽ POST	+4.05%	open_in_new
Mar 10, 2023	☽ POST	-2.34%	open_in_new
Nov 10, 2022	☽ POST	+5.78%	open_in_new
Aug 09, 2022	☽ POST	+11.88%	open_in_new
May 10, 2022	☽ POST	+0.98%	open_in_new
Mar 18, 2022	☽ POST	-9.49%	open_in_new
Nov 09, 2021	☽ POST	+5.62%	open_in_new
Aug 10, 2021	☽ POST	-2.3%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.86%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 21 →

Funds holding

$295187397

Total value held

Buying

20 added · 1 reduced

Blackrock, Inc.

$94228481 +12.91%

Janus Henderson Group Plc

$58279971 NEW BUY

State Street Corp

$46155249 +21.95%

Federated Hermes, Inc.

$36140959 NEW BUY

Goldman Sachs Group Inc

$14633088 +58.25%

SEC Filing Types

description SCHEDULE 13G/A

13 chevron_right

description SC 13D/A

12 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260813	open_in_new SEC.gov
10-Q	20260806	open_in_new SEC.gov
8-K	20260806	open_in_new SEC.gov
4	20260731	open_in_new SEC.gov
SCHEDULE 13G/A	20260728	open_in_new SEC.gov
4	20260710	open_in_new SEC.gov
8-K	20260623	open_in_new SEC.gov
4	20260612	open_in_new SEC.gov
4	20260612	open_in_new SEC.gov

Frequently asked about JANX earnings

When does Janux Therapeutics, Inc. report earnings next? expand_more

Janux Therapeutics, Inc. (JANX)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does JANX stock move after earnings? expand_more

Over 21 reports, JANX has moved an average of ±3.86% the session after earnings, closing higher 52.4% of the time.

What was JANX's biggest post-earnings move? expand_more

JANX's largest post-earnings gain on record was +11.88% on Aug 09, 2022, and its largest decline was -9.49% on Mar 18, 2022.

Where can I find Janux Therapeutics, Inc.'s SEC filings? expand_more

All of Janux Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.